BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17131129)

  • 1. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
    Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
    Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
    Rockenstein E; Ubhi K; Doppler E; Novak P; Moessler H; Li B; Blanchard J; Grundke-Iqbal I; Iqbal K; Mante M; Adame A; Crews L; Masliah E
    J Alzheimers Dis; 2011; 27(4):743-52. PubMed ID: 21860085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
    Rockenstein E; Desplats P; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
    Stem Cell Res; 2015 Jul; 15(1):54-67. PubMed ID: 26209890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
    Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
    J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
    Rockenstein E; Ubhi K; Pham E; Michael S; Doppler E; Novak P; Inglis C; Mante M; Adame A; Alvarez XA; Moessler H; Masliah E
    J Neurosci Res; 2011 Nov; 89(11):1812-21. PubMed ID: 21793038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.
    Rockenstein E; Adame A; Mante M; Larrea G; Crews L; Windisch M; Moessler H; Masliah E
    J Neural Transm (Vienna); 2005 Feb; 112(2):269-82. PubMed ID: 15657642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.
    Zhang C; McNeil E; Dressler L; Siman R
    Exp Neurol; 2007 Mar; 204(1):77-87. PubMed ID: 17070803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
    Ubhi K; Rockenstein E; Doppler E; Mante M; Adame A; Patrick C; Trejo M; Crews L; Paulino A; Moessler H; Masliah E
    Acta Neuropathol; 2009 Jun; 117(6):699-712. PubMed ID: 19252918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice.
    Niidome T; Taniuchi N; Akaike A; Kihara T; Sugimoto H
    Neuroreport; 2008 Sep; 19(14):1361-4. PubMed ID: 18766011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
    Liu H; Xue X; Shi H; Qi L; Gong D
    Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent alterations of the hippocampal cell composition and proliferative potential in the hAβPPSwInd-J20 mouse.
    Fu Y; Rusznák Z; Kwok JB; Kim WS; Paxinos G
    J Alzheimers Dis; 2014; 41(4):1177-92. PubMed ID: 24787919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
    Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
    Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
    Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
    Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin induces proliferation of neuronal progenitors and neuroprotection in a mouse model of Alzheimer's disease.
    Pérez-González R; Antequera D; Vargas T; Spuch C; Bolós M; Carro E
    J Alzheimers Dis; 2011; 24 Suppl 2():17-25. PubMed ID: 21335656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.
    Calingasan NY; Ho DJ; Wille EJ; Campagna MV; Ruan J; Dumont M; Yang L; Shi Q; Gibson GE; Beal MF
    Neuroscience; 2008 Jun; 153(4):986-96. PubMed ID: 18423880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.